Default Site Title

Hebrew University explore new methods to tackle COVID-19

Updated

2020-07-07

Researchers at the Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools and diagnostic capabilities. A number of researchers submitted proposals to the Israel Innovation Authority (IIA) today under the IIA’s program to fast track COVID-19 related research.

“We are reaching out to industry to help bring these ideas to fruition,” said Dr. Itzik Goldwaser, CEO of Yissum, the technology transfer company of the Hebrew University. “Among the early-stage technologies currently being developed are creative ideas spanning drug discovery, MedTech and medical equipment as well as systems to better diagnose and treat coronavirus. Our researchers have proposed a large number of ideas that include repurposing current drug treatments, face masks that can actively kill the Covid-19 virus, and even plant-based diagnostic tools and treatments.”

In addition to the research proposals submitted to the IIA, many Yissum subsidiaries have also rapidly adjusted to use their established core technologies to fight against the deadly virus.

Notable among them are:

Pepticom: Pepticom is implementing its proprietary core AI technology on various Coronavirus proteins and the ACE2 to identify novel inhibitors that can fight Sars Cov2. They are currently looking for partners to validate and develop these peptide drug candidates.

Enlivex: Has developed a medication that could help treat severe symptoms of COVID-19 including catastrophic organ failure.

Michael Furaev

Strategic partner

Head of Quattrgroup

Visionary leader and designer of synergistic teams

Anna Zharova

CEO of IUA

Entrepreneur and International Consultant, specializes in developing, managing and launching impact projects in commercial and social spheres

Co-founder of nonprofit organization "Israeli Friends of Ukraine"

Board Member in “Pnima” - Israeli organization, uniting public and government leaders

Eddy Dave

Chairman of IUA

15 years of experience in capital markets, investments, business development

Owner of Israeli-Ukrainian outsourcing company: 400 employees, 5 years of operations, offices in Kharkov and Kiev

Managing Partner of Camalia Capital Markets, which was successfully sold to Meitav Dash 5 years ago. Meitav Dash is the second biggest investment house in Israel with more than 50b$ at the disposal

Olha Stoliarchuk

Director of IUA

LL.M., Consultant, Project Manager, Attorney-at-Law

10 years of expertise in International and Ukrainian business and corporate law, energy law and antitrust law

Member of the GS Kyiv Hub community, WEF initiative

Co-founder of investment video blogs - VC ChatrOOm

https://www.linkedin.com/in/olha-stoliarchuk/

Daniil Tsiporukha

Co-founder of IUA

Social Media, Digital Marketing and Paid Ad Expert, Entrepreneur

Skilled in PPC, Analytics, Product Marketing, Start-ups, and Product Development

BA degree in Communications and New Media Studies IDC Herzliya, MA in Law ISU Kyiv

Co-Founder at Draw Days Tel-Aviv, IUA and Echo

Eugene Proskulikov

Communication expert

Design of social, corporate, and business relations by developing and implementing long-term communication strategies and ad hoc campaigns, based on data-driven analyst, creative approach, and coherent content policy

17 years of practice in communications as a strategist, analyst, copywriter, and marketing expert. Provided services for about 200 international and Ukrainian brands in various industries

Mykyta Khodakivskyi

Co-founder of IUA

An independent international expert that has been in software development, in particular, in cross-application development projects in global e-payments, eCommerce and FINTECH for nearly 15 years

Founder of Paris-based DevteamRadar.com, he runs consultancy and software development projects to assure successful launches for new startups and SaaS businesses